Company intelligence / Profile preview

Qkine

United Kingdom

Ownership: Private
Development stage: Other

Overview

Qkine’s animal-origin-free recombinant growth factors and cytokines are manufactured at high purity (≥98%), with rigorous lot-to-lot quality control and validated bioactivity for use in stem cell, organoid, and cellular agriculture applications; the company has launched food-grade growth factors and supports regulatory submissions for cultivated meat.

Therapeutic areas: Other
Modalities: Recombinant proteinCytokineProtein
Industry: Non-Drug Biotech

Partnerships

CPI (UK Centre for Process Innovation)Bezos Center for Sustainable Protein at Imperial College LondonNational Alternative Protein Innovation Centre (NAPIC)CARMA cellular agriculture manufacturing hub

Beyond the preview

Go deeper on Qkine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qkine.

Explore the full profile